Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05916222 · ClinicalTrials.gov registry record · NA

The Effects of Caregiver Training on DTTC Treatment Outcomes in CAS

A NA study of Childhood Apraxia of Speech, sponsored by New York University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
2
Study locations

NCT05916222 is a NA study of Childhood Apraxia of Speech that is actively recruiting participants, run by New York University. The registered enrollment target is 40 participants, below the 184-participant average among 3 other Childhood Apraxia of Speech trials with a reported enrollment target (78% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05916222, a NA study of Childhood Apraxia of Speech, is actively recruiting participants, sponsored by New York University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

The goal of this clinical trial is to investigate the impact of direct vs. indirect caregiver training on treatment outcomes following a period of Dynamic Temporal and Tactile Cueing (DTTC) intervention combined with home practice in childhood apraxia of speech (CAS). Forty children with CAS, between the ages of 2;5 and 7;11 years of age, will be recruited for this study. All children will receive DTTC treatment at the frequency of standard care (2x/week) in a university clinic over and 8-week period. Participants will be randomly assigned to one of two groups: the Direct Training Group; the Indirect Training Group. All caregivers will complete an educational module about CAS, will observe all sessions, and will engage in home practice with their children. Caregivers in the Direct Group will receive coaching in the use of DTTC with their child during a portion of each treatment session to support home practice, whereas those in the Indirect Group will not receive detailed guidance for home practice. Caregivers in both groups will practice at home with their children during the treatment phase (3x/week). Following the treatment phase, home practice will continue at a higher frequency (6x/week) during a 4-week follow-up phase. Treatment outcomes will be compared between groups.

Interventions

  • BEHAVIORAL Dynamic Temporal and Tactile Cueing (DTTC)

Study Locations (2)

New York

  • Hofstra University - Hempstead
  • New York University - New York

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-07-19
Est. Completion 2026-12-31
Phase NA

Sponsor

New York University

83 total trials

What the Registry Record Tells You About NCT05916222

The ClinicalTrials.gov registry entry for NCT05916222 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 184-participant average among 3 other Childhood Apraxia of Speech trials with a reported enrollment target (78% lower). The listed sponsor is New York University, which has 83 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Childhood Apraxia of Speech appearing as the primary indexed condition, and to 1 intervention - of which Dynamic Temporal and Tactile Cueing (DTTC) is the first listed.

NCT05916222 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05916222 about?

NCT05916222 is a clinical study titled "The Effects of Caregiver Training on DTTC Treatment Outcomes in CAS". The goal of this clinical trial is to investigate the impact of direct vs. indirect caregiver training on treatment outcomes following a period of Dynamic Temporal and Tactile Cueing (DTTC) intervention combined with home practice in childhood apraxia of speech (CAS). Forty children with CAS, betwee...

What is the current status of trial NCT05916222?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-07-19. Estimated completion is 2026-12-31.

What conditions does trial NCT05916222 study?

This clinical trial studies the following conditions: Childhood Apraxia of Speech.

What interventions are being tested in trial NCT05916222?

The interventions under investigation include: Dynamic Temporal and Tactile Cueing (DTTC) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05916222?

This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05916222 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Childhood Apraxia of Speech

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.